{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T21:07:24Z","timestamp":1788469644566,"version":"build-2803163510"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004410","name":"T\u00fcrkiye Bilimsel ve Teknolojik Ara\u015ftirma Kurumu","doi-asserted-by":"publisher","award":["119S367"],"award-info":[{"award-number":["119S367"]}],"id":[{"id":"10.13039\/501100004410","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microbial Pathogenesis"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.micpath.2021.105016","type":"journal-article","created":{"date-parts":[[2021,6,7]],"date-time":"2021-06-07T20:34:56Z","timestamp":1623098096000},"page":"105016","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["GRA8 DNA vaccine formulations protect against chronic toxoplasmosis"],"prefix":"10.1016","volume":"158","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2468-5564","authenticated-orcid":false,"given":"Muhammet","family":"Karakavuk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00fcseyin","family":"Can","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayt\u00fcl","family":"G\u00fcl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aysu De\u011firmenci","family":"D\u00f6\u015fkaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sedef Erkunt","family":"Alak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cemal","family":"\u00dcn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7920-9429","authenticated-orcid":false,"given":"Adnan Y\u00fcksel","family":"G\u00fcr\u00fcz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6868-008X","authenticated-orcid":false,"given":"Mert","family":"D\u00f6\u015fkaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.micpath.2021.105016_bib1","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0104930","article-title":"Genetic characterization of Toxoplasma gondii isolates and toxoplasmosis seroprevalence in stray cats of Izmir, Turkey","volume":"9","author":"Can","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.micpath.2021.105016_bib2","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1111\/j.1550-7408.1997.tb05965.x","article-title":"Bradyzoite-induced murine toxoplasmosis: stage conversion, pathogenesis, and tissue cyst formation in mice fed bradvzoites of - different strains of toxoplasma gondii","volume":"44","author":"Dubey","year":"1997","journal-title":"J. Eukaryot. Microbiol."},{"key":"10.1016\/j.micpath.2021.105016_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0196159","article-title":"Prevalence of toxoplasmosis and genetic characterization of Toxoplasma gondii strains isolated in wild birds of prey and their relation with previously isolated strains from Turkey","volume":"13","author":"Karakavuk","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.micpath.2021.105016_bib4","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1590\/S0074-02762009000200018","article-title":"Veterinary vaccines against Toxoplasma gondii","volume":"104","author":"Innes","year":"2009","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"10.1016\/j.micpath.2021.105016_bib5","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1645\/GE-3257.1","article-title":"Ante-mortem diagnosis, diarrhea, oocyst shedding, treatment, isolation, and genetic typing of Toxoplasma gondii associated with clinical toxoplasmosis in a naturally infected cat","volume":"99","author":"Dubey","year":"2013","journal-title":"J. Parasitol."},{"key":"10.1016\/j.micpath.2021.105016_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1297-9716-42-121","article-title":"Increased Toxoplasma gondii positivity relative to age in 125 Scottish sheep flocks; Evidence of frequent acquired infection","volume":"42","author":"Katzer","year":"2011","journal-title":"Vet. Res."},{"key":"10.1016\/j.micpath.2021.105016_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.fawpar.2019.e00037","article-title":"Toxoplasma gondii infection and toxoplasmosis in farm animals: risk factors and economic impact","volume":"15","author":"Stelzer","year":"2019","journal-title":"Food Waterborne Parasitol."},{"key":"10.1016\/j.micpath.2021.105016_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fmicb.2017.01825","article-title":"Sixty Years (1957-2017) of research on toxoplasmosis in China-An overview","volume":"8","author":"Pan","year":"2017","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.micpath.2021.105016_bib9","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.ijpara.2003.12.009","article-title":"Toxoplasma gondii: the model apicomplexan","volume":"34","author":"Kim","year":"2004","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.micpath.2021.105016_bib10","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1128\/CMR.05013-11","article-title":"Epidemiology of and diagnostic strategies for toxoplasmosis","volume":"25","author":"Robert-Gangneux","year":"2012","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.micpath.2021.105016_bib11","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1007\/s12275-017-7392-5","article-title":"Dense Granule Protein-7 (GRA-7) of Toxoplasma gondii inhibits viral replication in vitro and in vivo","volume":"55","author":"Weeratunga","year":"2017","journal-title":"J. Microbiol."},{"key":"10.1016\/j.micpath.2021.105016_bib12","author":"Zhou"},{"key":"10.1016\/j.micpath.2021.105016_bib13","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1017\/S0031182014001978","article-title":"Identification of Toxoplasma gondii antigens associated with different types of infection by serum antibody profiling","volume":"142","author":"Felgner","year":"2015","journal-title":"Parasitology"},{"key":"10.1016\/j.micpath.2021.105016_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0108329","article-title":"Diagnostic value of a Rec-ELISA Using toxoplasma gondii recombinant SporoSAG, BAG1, and GRA1 proteins in murine models infected orally with tissue cysts and oocysts","volume":"9","author":"D\u00f6\u015fkaya","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.micpath.2021.105016_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1074\/mcp.M110.006916","article-title":"Identification of potential serodiagnostic and subunit vaccine antigens by antibody profiling of toxoplasmosis cases in Turkey","volume":"10","author":"Liang","year":"2011","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.micpath.2021.105016_bib16","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0166-6851(99)00160-7","article-title":"Identification and molecular characterization of GRA8, a novel, proline- rich, dense granule protein of Toxoplasma gondii","volume":"105","author":"Carey","year":"2000","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.micpath.2021.105016_bib17","first-page":"145","article-title":"Bacterial production of dense granule antigen GRA8 of Toxoplasma gondii, Iran","volume":"13","author":"Babaie","year":"2009","journal-title":"Biomed. J."},{"key":"10.1016\/j.micpath.2021.105016_bib18","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1590\/S0074-02762009000200019","article-title":"Vaccines against toxoplasma gondii: challenges and opportunities","volume":"104","author":"Jongert","year":"2009","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"10.1016\/j.micpath.2021.105016_bib19","doi-asserted-by":"crossref","DOI":"10.1051\/parasite\/2017045","article-title":"Immune responses and protection after DNA vaccination against Toxoplasma gondii calcium-dependent protein kinase 2 (TgCDPK2)","volume":"24","author":"Chen","year":"2017","journal-title":"Parasite"},{"key":"10.1016\/j.micpath.2021.105016_bib20","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1016\/j.vaccine.2006.10.060","article-title":"GRA1 protein vaccine confers better immune response compared to codon-optimized GRA1 DNA vaccine","volume":"25","author":"D\u00f6\u015fkaya","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.micpath.2021.105016_bib21","first-page":"325","article-title":"Evaluation of protective immune response induced by a DNA vaccine encoding GRA8 against acute toxoplasmosis in a murine","volume":"56","author":"Chu","year":"2018","journal-title":"Model"},{"key":"10.1016\/j.micpath.2021.105016_bib22","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S1097-2765(02)00591-9","article-title":"Cholesterol addition to ER membranes alters conformation of SCAP, the SREBP escort protein that regulates cholesterol metabolism","volume":"10","author":"Brown","year":"2002","journal-title":"Mol. Cell."},{"key":"10.1016\/j.micpath.2021.105016_bib23","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1586\/erv.10.174","article-title":"CpG DNA as a vaccine adjuvant (author manuscript)","volume":"10","author":"Bode","year":"2011","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.micpath.2021.105016_bib24","doi-asserted-by":"crossref","first-page":"115403","DOI":"10.1016\/j.carbpol.2019.115403","article-title":"A fucoidan-quaternary chitosan nanoparticle adjuvant for anthrax vaccine as an alternative to CpG oligodeoxynucleotides","volume":"229","author":"Chuang","year":"2020","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.micpath.2021.105016_bib25","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1080\/08830180600743057","article-title":"Adjuvant activity of CpG oligodeoxynucleotides","volume":"25","author":"Klinman","year":"2006","journal-title":"Int. Rev. Immunol."},{"key":"10.1016\/j.micpath.2021.105016_bib26","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1517\/14712598.4.6.937","article-title":"Use of CpG oligodeoxynucleotides as immunoprotective agents","volume":"4","author":"Klinman","year":"2004","journal-title":"Expet Opin. Biol. Ther."},{"key":"10.1016\/j.micpath.2021.105016_bib27","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.intimp.2012.10.020","article-title":"CpG oligodeoxynucleotides with double stem-loops show strong immunostimulatory activity","volume":"15","author":"Yu","year":"2013","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.micpath.2021.105016_bib28","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1371\/journal.pone.0045152","article-title":"SVMTriP: a method to Predict antigenic epitopes using support vector machine to integrate tri-peptide similarity and propensity","volume":"7","author":"Yao","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.micpath.2021.105016_bib29","doi-asserted-by":"crossref","first-page":"107158","DOI":"10.1016\/j.compbiolchem.2019.107158","article-title":"Do Toxoplasma gondii apicoplast proteins have antigenic potential? An in silico study","volume":"84","author":"Can","year":"2020","journal-title":"Comput. Biol. Chem."},{"key":"10.1016\/j.micpath.2021.105016_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-020-79645-9","article-title":"In silico discovery of antigenic proteins and epitopes of SARS-CoV-2 for the development of a vaccine or a diagnostic approach for COVID-19","volume":"10","author":"Can","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.micpath.2021.105016_bib31","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1093\/glycob\/cwh151","article-title":"Prediction, conservation analysis, and structural characterization of mammalian mucin-type O-glycosylation sites","volume":"15","author":"Julenius","year":"2005","journal-title":"Glycobiology"},{"key":"10.1016\/j.micpath.2021.105016_bib32","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1006\/jmbi.1999.3310","article-title":"Sequence and structure-based prediction of eukaryotic protein phosphorylation sites","volume":"294","author":"Blom","year":"1999","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.micpath.2021.105016_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13071-018-2934-1","article-title":"Discovery of new Toxoplasma gondii antigenic proteins using a high throughput protein microarray approach screening sera of murine model infected orally with oocysts and tissue cysts","volume":"11","author":"D\u00f6\u015fkaya","year":"2018","journal-title":"Parasites Vectors"},{"key":"10.1016\/j.micpath.2021.105016_bib34","doi-asserted-by":"crossref","DOI":"10.1021\/nl300027p","article-title":"Surface-engineered gold nanorods: promising DNA vaccine adjuvant for HIV-1 treatment","volume":"12","author":"Xu","year":"2012","journal-title":"Nano Lett."},{"key":"10.1016\/j.micpath.2021.105016_bib35","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.trivac.2015.11.002","article-title":"Immunogenic multistage recombinant protein vaccine confers partial protection against experimental toxoplasmosis mimicking natural infection in murine model","volume":"5","author":"Gedik","year":"2016","journal-title":"Trials Vaccinol."},{"key":"10.1016\/j.micpath.2021.105016_bib36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.exppara.2011.01.019","article-title":"Toxoplasma gondii RH Ankara: production of evolving tachyzoites using a novel cell culture method","volume":"128","author":"De\u011dirmenci","year":"2011","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.micpath.2021.105016_bib37","doi-asserted-by":"crossref","first-page":"44","DOI":"10.5152\/tpd.2013.11","article-title":"[Cryopreservation of Toxoplasma gondii tachyzoites and tissue cysts]","volume":"37","author":"D\u00f6\u015fkaya","year":"2013","journal-title":"Turk. Parazitoloji Derg."},{"key":"10.1016\/j.micpath.2021.105016_bib38","doi-asserted-by":"crossref","first-page":"122","DOI":"10.5578\/mb.4348","article-title":"No Title comparison of immune responses elicited by adjuvanted tachyzoite lysate vaccines developed from two different toxoplasma gondii strains isolated in Turkey","volume":"47","author":"Polat","year":"2013","journal-title":"Mikrobiyoloji Bulteni"},{"key":"10.1016\/j.micpath.2021.105016_bib39","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1006\/bbrc.2001.4577","article-title":"Uncoupling protein-2 participates in cellular defense against oxidative stress in clonal \u03b2-cells","volume":"282","author":"Li","year":"2001","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.micpath.2021.105016_bib40","first-page":"111","article-title":"Comparison of two proliferation assays MTT and ltt in immunodeficient patients","volume":"2","author":"Isaian","year":"2003","journal-title":"Iran. J. Allergy, Asthma Immunol."},{"key":"10.1016\/j.micpath.2021.105016_bib41","doi-asserted-by":"crossref","DOI":"10.1017\/S003118200000144X","article-title":"A commercial vaccine for ovine toxoplasmosis","volume":"110","author":"Buxton","year":"1995","journal-title":"Parasitology"},{"key":"10.1016\/j.micpath.2021.105016_bib42","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S1286-4579(03)00048-0","article-title":"Development of a vaccine for toxoplasmosis: current status","volume":"5","author":"Bhopale","year":"2003","journal-title":"Microb. Infect."},{"key":"10.1016\/j.micpath.2021.105016_bib43","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1292\/jvms.63.433","article-title":"Modified protection against toxoplasma gondii lethal infection and brain cyst formation by vaccination with SAG2 and SRS1","volume":"63","author":"Mishima","year":"2001","journal-title":"J. Vet. Med. Sci."},{"key":"10.1016\/j.micpath.2021.105016_bib44","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.exppara.2005.11.009","article-title":"Toxoplasma gondii: DNA vaccination with bradyzoite antigens induces protective immunity in mice against oral infection with parasite cysts","volume":"112","author":"Nielsen","year":"2006","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.micpath.2021.105016_bib45","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1128\/JCM.38.3.1144-1150.2000","article-title":"Recombinant antigens to detect Toxoplasma gondii-specific immunoglobulin G and immunoglobulin M in human sera by enzyme immunoassay","volume":"38","author":"Aubert","year":"2000","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.micpath.2021.105016_bib46","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1128\/JCM.38.1.179-184.2000","article-title":"Serodiagnosis of recently acquired Toxoplasma gondii infection with a recombinant antigen","volume":"38","author":"Li","year":"2000","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.micpath.2021.105016_bib47","first-page":"67","article-title":"Expression and single-step purification of GRA8 antigen of toxoplasma","volume":"3","author":"Babaie","year":"2011","journal-title":"Avicenna J. Med. Biotechnol. (AJMB)"},{"key":"10.1016\/j.micpath.2021.105016_bib48","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.mimet.2018.04.015","article-title":"Semiquantitative Dot Blot with the GRA8 antigen to differentiate the stages of toxoplasmosis infection","volume":"149","author":"Costa","year":"2018","journal-title":"J. Microbiol. Methods"},{"key":"10.1016\/j.micpath.2021.105016_bib49","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.parint.2008.05.001","article-title":"Evaluation of the immune response elicited by multi-antigenic DNA vaccine expressing SAG1, ROP2 and GRA2 against Toxoplasma gondii","volume":"57","author":"Xue","year":"2008","journal-title":"Parasitol. Int."},{"key":"10.1016\/j.micpath.2021.105016_bib50","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1186\/1756-3305-4-213","article-title":"DNA vaccination with a gene encoding Toxoplasma gondii GRA6 induces partial protection against toxoplasmosis in BALB\/c mice","volume":"4","author":"Sun","year":"2011","journal-title":"Parasites Vectors"},{"key":"10.1016\/j.micpath.2021.105016_bib51","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1111\/pbi.12001","article-title":"A chloroplast-derived Toxoplasma gondii GRA4 antigen used as an oral vaccine protects against toxoplasmosis in mice","volume":"10","author":"Y\u00e1cono","year":"2012","journal-title":"Plant Biotechnol. J."}],"container-title":["Microbial Pathogenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401021002886?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401021002886?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:33:47Z","timestamp":1760110427000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0882401021002886"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":51,"alternative-id":["S0882401021002886"],"URL":"https:\/\/doi.org\/10.1016\/j.micpath.2021.105016","relation":{},"ISSN":["0882-4010"],"issn-type":[{"value":"0882-4010","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"GRA8 DNA vaccine formulations protect against chronic toxoplasmosis","name":"articletitle","label":"Article Title"},{"value":"Microbial Pathogenesis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.micpath.2021.105016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105016"}}